Академический Документы
Профессиональный Документы
Культура Документы
Embryological background:
(1) Skin:
The skin and its associated structures, the hair, nails, and glands are
derived from surface ectoderm[1]. Melanocytes, which give the skin its color, are
derived from neural crest cells, which migrate into the epidermis[2]. The
production of new cells occurs in the germinative layer. After moving to the
surface, cells are sloughed off in the horny layer [2]. The dermis, the deep layer
of the skin, is of mesenchymal origin.
Hairs develop from down growth of epidermal cells in the underlying
[3]
dermis . By about 20 weeks, the fetus is covered by downy hair, lanugo hair,
which is shed at the time of birth[3]. Sebaceous glands, sweat glands and
mammary glands all develop from epidermal proliferations[4].
I. Developmental Defects:
(A) Cutaneous manifestations of neural tube defects (Dysraphism)
1] Cranial Dysraphism :
a- Cephaloceles
Cephalocele is the general term for congenital herniation of intracranial
structures through a scalp defect. Meningoceles are congenital lesions in which
only the meninges and cerebrospinal fluid herniated through a calvarial defect.
Large encephaloceles and meningoceles pose no diagnostic problems and easily
diagnosed prenatally or at birth. Smaller or atretic encephaloceles and meningo-
celes may be mistaken for cutaneous lesions such as hematoma, hemangiomas,
aplasia cutis, dermoid cysts, or inclusion cysts. All congenital, exophytic scalp
nodules should be evaluated thoroughly as 20 % to 37% of congenital non
traumatic scalp nodules connect to the underlying CNS[7]. If congenital nodule
occurs in association with cutaneous abnormalities, the diagnosis of cranial
dysraphism is highly suspect. Cutaneous stigmata of cranial dysraphism include
hypertrichosis or the "hair collar sign", capillary malformations, hemangiomas,
and cutaneous dimples and sinuses [8]. The hair collar sign may be found in
association with encephaloceles, meningoceles, atretic encephaloceles, atretic
meningoceles an heterotopic brain tissue but it also may be found with some
lesions of aplasia cutis. So this sign is not entirely specific [9]. From a clinical
stand point encephaloceles, meningoceles, atretic cephaloceles, heterotopic
brain tissue are impossible to differentiate, and all should be imaged and
surgically corrected as soon as possible to prevent complications .
b- Cranial dermoid cyst and sinuses:
Dermoid cysts are congenital subcutaneous lesions that are distributed
along embryonic fusion lines. The cysts may occur within the fusion lines of
the facial processes or within the neural axis [10]. Midline or nasal dermoid cysts
are of greater concern because 25% of these have an intracranial connection.
A nasal pit or sinus is present approximately in 25% of cases [11].
If the dermoid cyst connects to CNS, cerebrospinal fluid may drain from
the sinus. Dermal sinuses are 1-5 mm tracts that connect a dermoid cyst to the
skin surface. These usually are midline, found on the nose, occipital scalp and
anywhere along the spinal axis. They become clinically apparent when they
become infected and drain purulent material. A small tuft of hair is often found
protruding from the orifice. If the sinus or cyst directly communicates with the
CNS, the patient is at risk for meningitis. The sinus serves as an occult portal of
entry for bacteria often causing a recurrent meningitis. A thorough search for
Skin of Neonates as a Neurodevelopmental Interface
3
cutaneous fistulas should be carried out and may necessitate shaving the scalp
hair[12].
2] Spinal Dysraphism
This term encompasses many congenital anomalies of the spine including [13,14].
• Meningocele.
• Myelomeningoceles (Fig. 1)
• Myeloschisis
• Occult spina bifida
• Diastematomyelia
• Diplomyelia
• Tethered conus
• Intraspinal lipoma
• Lipomyelomeningocele
• Dermoid cyst Fig. (1): Myelomeningocele
• Dermal sinus.
II. Geno-Dermatoses:
Skin is considered to be a "pressure value" for the rest of the body, with
cutaneous disorders simply reflecting derangement of the humors that governed
bodily function. Although skin is now thought to be distinct cutaneous marker,
commonly betray the presence of a genetic disorder. In many cases, skin
findings are the initial manifestations of genetic disease allowing early diagnosis
and intervention.
(1) Neurofibromatosis type 1 (NF-1):
Neurofibromatosis type 1 (NF-1) or Von Recklinghausen disease, is an
autosomal dominant inherited neurocutaneous syndrome that affects 1 in 3000
individuals world wide [38]. The primary cutaneous findings in patients with NF-
1 is café au lait macule (CALM). CALMs are tan macules and patches that are
often present at birth but may develop during the first 5 years of life. Isolated
CALMs are common in general populations however six or more lesions
measuring 0.5 cm or more is one diagnostic criterion for the diagnosis of
NF-1[39]. Other major features that aid in establishing a diagnosis of NF-1 include
axillary or inguinal frecklings, dermal or plexiform (deeper) neurofibroma,
bilateral lisch nodules (iris hamartomas), optic gliomas, pseudoarthrosis of tibia
and sphenoid wing dysplasia. Typically at birth it can present itself as CALMs,
plexifrorm neurofibromas and/or tibial dysplasia (Table 1) [40].
Table (1): Age dependent presentation of NF-1
reported [48], but usually the skin is dry and mildly erythrodermic at birth , and
scaling develops within the first 3 months of life.
Neurological dysfunction is obvious in early infancy, with delayed motor
milestones and evolution of upper motor neuron signs in the legs and rarely in
the arms also. The motor features are of a typical, non progressive spastic
paraparesis. Altered posture and movement may lead to skeletal defects . Mild
to moderate mental disability is the rule [49].
Skin of Neonates as a Neurodevelopmental Interface
11
REFERENCES
1. Holbrook KA, Hoff MS.: Structure of the developing human embryo and fetal
skin. Seminar Dermatol; 3:185-202, 1984.
2. Smith LT, Holbrook KA: Embryogenesis of the dermis in human skin . Pediatric
Dermatol; 3:271, 1986.
3. Holbrook KA, Odland GF: Structure of the human fetal hair canal and initial
hair eruption. J Invest Dermatol; 71:385-90, 1978.
4. Sato S, Hiraga K, Nishiyrma A, et al.: Neonatal sebaceous glands: Fine structure
of sebaceous and denderitic cells . Acta Derm Venereol (stockh), 57:279-87,
1977.
5. Muller F, O'Rahilly R: The development of the human brain from a closed neural
tube. Anat Embryol 177:203, 1986.
6. Muller F, O' Rahilly R: The development of the human brain and the closure of
the rostral neuropore. Anat Embryol 175:205, 1986.
7. Oakes W: Butterfly-shaped mark. Pediatrics 87:956-957, 1991.
8. Drolet B,Clowry Jr L, McTigue K, et al: The hair collar sign: A cutaneous marker
for neural tube dysraphism. Pediatrics 96:309-313, 1995.
9. Drolet B, prendiville J, Golden J, et al: Membranous aplasia cutis with hair
collars: Congenital absence of the skin or neuro ectodermal defect? Arch
Dermatol 131: 1427:1431, 1995.
10. Powell K, Cherry J, Hougen T, et al: A prospective search for congenital dermal
abnormalities of the craniospinal axis. J Pediatr. 87:744-750, 1975.
11. Peter J, Sinclair – Smith C Devilliers J: Midline dermal sinuses and cysts and
their relationship to the central nervous system. Eur J Pediatr Surg. 1:73-79,
1991.
12. Kriss VM, Desal NS: Occult spinal dysraphism in neonates: Assessment of high-
risk cutaneous stigmata on sonography. AJR Am J Roentgenol 171:1687-
1692-1998.
13. Burrows F: Some aspects of occult spinal dysraphism: A study of 90 cases. Br J
Radiol 41:487, 1968.
14. Raghavendra B, Epstein F, Pinto R, et al: The tethered cord: Diagnosis by high
resolution real time ultrasound. Radiology 149:123-128, 1983.
15. Albright A, Gartner J, Weiner E: Lumbar cutaneous hemangimas as indicators of
tethered spinal cords. Pediatrics 83:977-980, 1989.
16. Anderson F: Occult spinal dysraphism: A series of 73 cases. Pediatrics 55:826-
829, 1975.
Skin of Neonates as a Neurodevelopmental Interface
22
34. Dodge NN, Dobyns WB.: Agenesis of the corpus callosum and Dandy- Walker
malformation associated with hemimegalencephaly in the sebaceous naevus
syndrome. A M J Med Genet 56:147-150, 1995.
35. Moskwitz R,Honig PJ.: Naevus sebaceous in association with an intracranial
mass. J Am Acad Dermatol 6:1078-1080, 1982.
36. Rogress M, McCrossen L, Commens C: Epidermal nevi and the epidermal nevus
syndrome. J Am Acad Dermatol 20:476-488, 1989.
37. Zvulunov A, Esterely N: Neurocutaneous syndromes associated with pigmentary
skin lesions . J Am Acad Dermatol 32:915-935, 1995.
38. Friedman JM: Epidemiology of neurofibromatosis type 1. Am J Med Genet 1:89,
1999.
39. Landau M, Krafchik BR: The diagnostic value of café' au lait macules. J Am
Acad Dermatol 40:877, 1999.
40. Gutmann DH, Aylsworth A, Carey K, et al: The diagnostic evaluation and
multidisciplinary management of neurofibromatosis 1 and neurofibromatosis
2. JAMA 51:278, 1997.
41. Vanderhoof SL, Francis JS, Pagon RA, et al: Prevalence of hypopigmented
macules in a healthy population. J Pediatr 129:355, 1996.
42. Webb DW, Clarke A, Fryer A, et al.: Cutaneous features of tuberous sclerosis: A
population study. Br J Dermatol 135:1-5, 1996.
43. Kwiatkowski DJ, Short MP: Tabcrous sclerosis. Arch Dermatol 130:348-354,
1994.
44. Park JP, Graham JM, Andrews PA, et al.: Ring chromosome 12. Am J Med
Genet 29:437-440, 1988.
45. Fagan K, Suthers GK, Hardacre G.: Ring chromosome 11 and café' au lait spots.
Am J Med Genet 30:911-916, 1988.
46. McDonald WB, Fitch KD, Lewis JC: Cockayne's syndrome. A heredofamilial
disorder of growth and development. Pediatrics 25:997-1007, 1960.
47. Lieberman WJ, Schimek RA, Snyder CH: Cockayne's disease. A report of a
case. Am J Ophthalmol 52:116-118, 1961.
48. Larregue M, Ottavy N, Bressieux JM, et al: Be'Be' collodion; trente deux
nouvelles observations. Ann Dermatol Vene'reol 113:773-785, 1986.
49. Commori JM, Leibovici V, Ziotogorski A.: Compound tomography in Sjogren
Larsson syndrome. Neuroradiol 29:557-559, 1987.
50. Carney RG. Incontinentia pigment: A world statistical analysis. Arch Dermatol
112:535-542, 1976.
51. Francis JS, Sybert VP: Incontinentia pigment. Semin Cutan Med Surg 16:54,
1997.
Skin of Neonates as a Neurodevelopmental Interface
24
69. Doppman JL, Wirth FP, Dichiro G, et al.: Value of cutaneous angiomas in the
angiographic localization of spinal cord arteriovenous malformations. N
Engl J Med 281:1440-1444, 1969.
70. Zaremba I, Stepien M, Jelowicka M, et al: Hereditary neurocutaneous angioma: A
new genetic entity? J Med Genet 16:443-447, 1979.
71. Libow LF.: Phakomatosis pigmentovascularis type IIIB. J Am Acad Dermatol
29:305-307, 1993.
72. Christoferson LA, Gustafson MB, Peterson AG.: Von Hippel – Lindau's disease.
JAMA 178:280-282, 1991.
73. Grigor R, Edmonds J, Lewkonia R, et al: Systemic lupus erythematosus: A
prospective analysis. Ann Rheum Dis 37:121-128, 1978.
74. Feinglass EJ, Amett FC, Dorsch CA, et al: Neuropsychiatric manifestations of
systemic lupus erythematosus: diagnosis, clinical spectrum and
relationship to other features of the disease. Medicine 55:323-339, 1976.
76. Akman – Demic G, Serdaroglu P, Tasci B: Clinical patterns of neurological
involvement in Behcet's disease: Evaluation of 200 patients. Brain
122:2171-2182, 1999.
75. Sakane T, Takeno M, Suzuki N, et al.: Behcet's disease. N Engl J Med
342:1284-1291, 1999.
77. Akman Demir G, Baykan- Kurt B, Sendaroglu P, et al: Seven- year follow-up of
neurologic involvement in Behcet syndrome. Arch Neurol 53:691-694,
1996.
78. Guttler F, Guldberg P: Mutations in the phenyl alanine hydroxylase gene: genetic
determinants locus in the human genome. Acta Paediatr Suppl 407:49-56,
1994.
79. Jablonska S, Stachow A, Suffezynska M.: Skin and muscle indurations in
phenylketonuria. Arch Dermatol 95:443-450, 1967.
80. Walter TH: Late effects of phenyketonuria . Arch Dis Child 73:485-486, 1995.
81. Remington SJ, Klein OJ,: Infectious Diseases of the fetus and newborn infant. N
Engl J Med 333:531-532, 1995, (book review).
82. Williamson WD, Percy AK, Yow MD, et al: Asymptomatic congenital
cytomegalovirus infection audiologic, neuroradiologic and
neurodevelopmental abnormalities during the first year. Am J Dis Child
144:1365-1368, 1990.
83. Lazzarotto T, Varani S, Guerra B, et al: Prenatal indicators of congenital
cytomegalovirus infection. J Paediatr 137:4-6, 2000.
84. Cetta F,Lambert GH,Ros SP: Newborn chemical exposure from over the counter
skin care products. Clin Pediatr 30:286-289, 1991.
Skin of Neonates as a Neurodevelopmental Interface
26
85. Haprpin VA, Rutter N: Barrier properties of the newborn infant's skin. J Pediatr
102:419-425, 1983.
86. Darmstadt GL, Dinulos JG: Neonatal skin care. Pediatr Clinc North Am 47:757-
782, 2000.